A Meta-analysis of Therapeutic Effect of Thalidomide on Ankylosing Spondylitis

Yukun Yao (Hebei University of Chinese Medicine)
Xin Liu (Hebei University of Chinese Medicine)

Abstract

Objective: To study the therapeutic effect of thalidomide on ankylosing spondylitis (AS) by meta-analysis. Methods: Personal digital library, Cochrane library, and China Biology Medicine disc (CMBdisc), as well as relevant pharmaceutical and medical journals, were collected and reviewed. After the analysis of characteristics of the selected document and the evaluation of the risk of bias, the therapeutic effect of thalidomide on ankylosing spondylitis (AS) and its influence on related indexes were analyzed by literature data. Results: The meta-analysis results of 8 pieces of literature showed that the total effective rate of thalidomide in the treatment of ankylosing spondylitis (AS) was significantly improved, compared with conventional treatment or sulfasalazine (SASP) treatment (P＜0.05). Furthermore, the time of morning stiffness, BASDAI score, C-reactive protein (CRP) level, and other related symptoms and indexes were significantly optimized (P＜0.05). Conclusion: By rational utilization of thalidomide in the treatment of ankylosing spondylitis (AS), related symptoms and indexes of patients can be effectively improved, the total effective rate of the treatment was significantly improved and the safety of the treatment can be guaranteed.

Keywords

Meta-analysis; Ankylosing spondylitis;Thalidomide; Clinical efficacy

Full Text:

PDF

References

XIE DH. Discussion on the therapeutic effect of thalidomide on patients with ankylosing spondylitis[J]. The Medical Forum, 2020, 24(17):2405-2406.

DOI: 10.19435/j.1672-1721.2020.17.021

WANG Z, ZHAO XY, QUAN BT, HUANG GQ. Efficacy and safety of thalidomide in the treatment of ankylosing spondylitis[J]. Clinical Research and Practice, 2019(14):30-32.

DOI:CNKI:SUN:YLYS.0.2019-14-012

RAN J. Observation of therapeutic effect of thalidomide on ankylosing spondylitis[J]. Contemporary Medical Symposium, 2019 (01):137-138.

DOI:10.3969/j.issn.2095-7629.2019.01.105

HOU T. Analysis of the therapeutic effect of thalidomide on ankylosing spondylitis [J]. Henan Medical Research, 2018 (04):662-663.

ZENG XL. Analysis of long-term efficacy and safety of thalidomide in the treatment of ankylosing spondylitis[J]. Journal of Qiqihar Medical College, 2017 (20):2412-2414.

GUI YL, SHI LP, XUN W, LIU ZD, HAN D, LI TR. Observation of efficacy and safety of thalidomide in the treatment of ankylosing spondylitis[J]. Modern Diagnosis and Treatment, 2017 (18):3382-3384.

DOI:10.3969/j.issn.1001-8174.2017.18.029

LI GK, YUAN Y. Analysis of the efficacy of thalidomide on ankylosing spondylitis [J]. China Practical Medicine, 2016 (23):1-3.

DOI: 10.14163/j.cnki.11-5547/r.2016.23.001

LI YH, TAO LH, QIAN KW. Clinical efficacy of thalidomide on ankylosing spondylitis and its effect on the expression of inflammatory factors[J]. Shanxi Medical Journal, 2016 (03):247-249.

DOI: 10.3969/j.issn.0253-9926.2016.03.002

DOI: https://doi.org/10.30564/jams.v3i3.2271